Citigroup Initiates Coverage On Minimed Group with Buy Rating, Announces Price Target of $23

Citigroup analyst Joanne Wuensch has initiated coverage on Minimed Group (NASDAQ: MMED) with a Buy rating. The firm has set a price target of $23 for the company's stock.